MARCAINE Side Effects

7020447-7 | Pyrexia
on Sep 20, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with anaesthesia, procedural pain, postoperative wound infection, thrombosis prophylaxis, bradycardia and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia. Marcaine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), CELECOXIB (600 Mg (first Dose 400 Mg , Second Dose 200 Mg)) (View Celecoxib Review and Celecoxib Label ), CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), HEPARIN CALCIUM (View Heparin Calcium Review and Heparin Calcium Label ), ATROPINE (View Atropine Review and Atropine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), RINGER'S AND DEXTROSE INJECTION (View Ringer's And Dextrose Injection Review and Ringer's And Dextrose Injection Label ), SOLITA T (View Solita T Review and Solita T Label ). Patient was hospitalized.

6971852-6 | Anaesthetic Complication, Product Quality Issue
Patient was taking Marcaine (View Usage). Patient had the following side effects: anaesthetic complication, product quality issue on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 227.1 lb, was diagnosed with spinal anaesthesia and. Marcaine dosage: Once Epidural.

6971851-4 | Anaesthetic Complication, Product Quality Issue
Adverse event was reported on Sep 08, 2010 by a Female patient taking Marcaine (View Usage) (Dosage: Once Epidural) was diagnosed with spinal anaesthesia and. Location: UNITED STATES , 29 years of age, weighting 169.8 lb, After Marcaine was administered, patient had the following side effects: anaesthetic complication, product quality issue.

6963972-7 | Product Quality Issue, Unwanted Awareness During Anaesthesia
on Sep 02, 2010 Male patient from UNITED STATES , 58 years of age, weighting 185.0 lb, was diagnosed with surgery (What is surgery?) and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue, unwanted awareness during anaesthesia. Marcaine dosage: 11.25mg One Time Intradiscal (.


6922614-7 | Cardiac Failure, Respiratory Failure
on Aug 09, 2010 Female patient from UKRAINE , 29 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). Patient had the following side effects: cardiac failure, respiratory failure. Marcaine dosage: . During the same period patient was treated with ATROPINE SULPHATE (View Atropine Sulphate Review and Atropine Sulphate Label ), DIMEDROL (View Dimedrol Review and Dimedrol Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6914506-4 | Blood Pressure Decreased, Dyspnoea, Foetal Hypokinesia, Renal Disorder
Patient was taking Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: blood pressure decreased, dyspnoea, foetal hypokinesia, renal disorder on Aug 03, 2010 from RUSSIAN FEDERATION Additional patient health information: Female patient , 23 years of age, weighting 211.6 lb, was diagnosed with spinal anaesthesia and. Marcaine dosage: .

6910491-X | Cauda Equina Syndrome, Dysuria, Muscular Weakness, Neurotoxicity, Nocturia, Spinal Cord Compression
Adverse event was reported on Jul 29, 2010 by a Male patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with knee arthroplasty and. Location: KOREA, REPUBLIC OF , 68 years of age, Patient experienced the following unwanted or unexpected effects: cauda equina syndrome, dysuria, muscular weakness, neurotoxicity, nocturia, spinal cord compression. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized and became disabled.

6855899-6 | Anorectal Disorder, Monoplegia
on Jul 08, 2010 Female patient from JAPAN , 60 years of age, weighting 136.7 lb, was diagnosed with spinal anaesthesia, epidural test dose and was treated with Marcaine (View Usage). Patient had the following side effects: anorectal disorder, monoplegia. Marcaine dosage: . During the same period patient was treated with POPSCAINE (4 Ml/hr Continuous Epidural.) (View Popscaine Review and Popscaine Label ), XYLOCAINE (4 Ml Was Administered Via L3/4 Veretbral Interspace.) (View Xylocaine Review and Xylocaine Label ).

6809437-4 | Meningitis Chemical
on Jun 18, 2010 Female patient from JAPAN , 34 years of age, was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: meningitis chemical. Marcaine dosage: . During the same period patient was treated with DIBUCAINE (View Dibucaine Review and Dibucaine Label ).

6801976-5 | Headache, Musculoskeletal Stiffness, Pyrexia
Patient was taking Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), musculoskeletal stiffness, pyrexia on Jul 21, 2008 from SWEDEN Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with renal pain and. Marcaine dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), MORPHINE SPECIAL (View Morphine Special Review and Morphine Special Label ). Patient was hospitalized.

6801938-8 | Headache, Medical Device Complication, Meningitis, Musculoskeletal Stiffness, Pyrexia
Adverse event was reported on Jun 27, 2008 by a Female patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with proctalgia and. Location: SWEDEN , weighting 105.8 lb, Patient had the following side effects: headache (What is headache?), medical device complication, meningitis (What is meningitis?), musculoskeletal stiffness, pyrexia. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), MORPHINE SPECIAL (View Morphine Special Review and Morphine Special Label ). Patient was hospitalized.

6785820-0 | Pre-eclampsia
on Jun 18, 2010 Female patient from BELGIUM , weighting 233.7 lb, was diagnosed with caesarean section and was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: pre-eclampsia. Marcaine dosage: 10 Mgr, Daily Dose.

6783993-7 | Anaesthetic Complication
on Jun 14, 2010 Female patient from HONG KONG , 80 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication. Marcaine dosage: .

6771856-2 | Meningitis Chemical
Patient was taking Marcaine (View Usage). Patient had the following side effects: meningitis chemical on Jun 09, 2010 from JAPAN Additional patient health information: Female patient , 34 years of age, . Marcaine dosage: .

6771116-X | Anaesthetic Complication, Paralysis
Adverse event was reported on Jun 14, 2010 by a Female patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with labour complication and. Location: UNITED STATES , 40 years of age, weighting 152.1 lb, After Marcaine was administered, patient had the following side effects: anaesthetic complication, paralysis (What is paralysis?).

6765870-0 | Pre-eclampsia
on Jun 07, 2010 Female patient from BELGIUM , weighting 233.7 lb, was diagnosed with caesarean section and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia. Marcaine dosage: 10 Mgr, Daily Dose.

6758031-2 | Cardiac Failure, Respiratory Failure
on Jun 02, 2010 Female patient from UKRAINE , 29 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). Patient had the following side effects: cardiac failure, respiratory failure. Marcaine dosage: . During the same period patient was treated with ATROPINE SULPHATE (View Atropine Sulphate Review and Atropine Sulphate Label ), DIMEDROL (View Dimedrol Review and Dimedrol Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6741012-2 |
Patient was taking Marcaine (View Usage). on May 20, 2010 from UKRAINE Additional patient health information: Female patient , 29 years of age, was diagnosed with anaesthesia and. Marcaine dosage: .

6737581-9 | Abdominal Pain, Altered State Of Consciousness, Hypersensitivity, Hypotension, Rash
Adverse event was reported on May 13, 2010 by a Female patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with arthralgia, osteoarthritis (What is osteoarthritis?), hypothyroidism and. Location: UNITED KINGDOM , 76 years of age, weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), altered state of consciousness, hypersensitivity, hypotension, rash (What is rash?). During the same period patient was treated with DEPO MEDROL (View Depo-medrol Review and Depo-medrol Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6673222-7 | Cauda Equina Syndrome
on Apr 05, 2010 Female patient from JAPAN , 40 years of age, was treated with Marcaine (View Usage). Patient had the following side effects: cauda equina syndrome. Marcaine dosage: .

6569275-7 | Inadequate Analgesia
on Feb 01, 2010 Female patient from UNITED STATES , 86 years of age, weighting 144.4 lb, was diagnosed with knee arthroplasty, spinal anaesthesia and was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: inadequate analgesia. Marcaine dosage: 1.7 Ml One Time Dose Intrathcal.

6543183-X | Circulatory Collapse
Patient was taking Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse on Jan 18, 2010 from POLAND Additional patient health information: Female patient , 63 years of age, weighting 180.8 lb, was diagnosed with anaesthesia and. Marcaine dosage: .

6502733-X | Arrhythmia Supraventricular, Convulsion
Adverse event was reported on Dec 08, 2009 by a Female patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: JAPAN , 71 years of age, weighting 105.8 lb, Patient had the following side effects: arrhythmia supraventricular, convulsion. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), ROPION (View Ropion Review and Ropion Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ULTIVA (View Ultiva Review and Ultiva Label ).

6480500-3 | Arrhythmia Supraventricular, Convulsion
on Nov 30, 2009 Female patient from JAPAN , 71 years of age, weighting 105.8 lb, was diagnosed with local anaesthesia and was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: arrhythmia supraventricular, convulsion. Marcaine dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), ROPION (View Ropion Review and Ropion Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ULTIVA (View Ultiva Review and Ultiva Label ).

6477590-0 | Arrhythmia, Syncope
on Nov 26, 2009 Male patient from SWEDEN , 27 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), syncope. Marcaine dosage: 5 Mg/ml Single Administration.

6473041-0 | Cauda Equina Syndrome
Patient was taking Marcaine (View Usage). Patient had the following side effects: cauda equina syndrome on Nov 09, 2009 from BELGIUM Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with anaesthesia and. Marcaine dosage: . During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

6442181-4 | Muscular Weakness
Adverse event was reported on Nov 05, 2009 by a Male patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with procedural pain and. Location: SWEDEN , weighting 195.6 lb, After Marcaine was administered, patient had the following side effects: muscular weakness. Patient was hospitalized.

6413818-0 |
on Oct 20, 2009 Female patient from FRANCE , child 7 years of age, was diagnosed with anaesthesia, postoperative analgesia and was treated with Marcaine (View Usage). . Marcaine dosage: .

6402091-5 | Paraplegia
on Oct 06, 2009 Male patient from JAPAN , 19 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). Patient had the following side effects: paraplegia. Marcaine dosage: .

6399615-3 | Cauda Equina Syndrome
Patient was taking Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: cauda equina syndrome on Oct 06, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 80 years of age, was diagnosed with local anaesthesia and. Marcaine dosage: .

6383745-6 | Anaesthetic Complication
Adverse event was reported on Sep 24, 2009 by a Male patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia and. Location: IRELAND , weighting 264.6 lb, Patient experienced the following unwanted or unexpected effects: anaesthetic complication.

6382821-1 | Joint Swelling, Staphylococcal Infection
on Sep 28, 2009 Male patient from UNITED STATES , 50 years of age, weighting 235.0 lb, was treated with Marcaine (View Usage). Patient had the following side effects: joint swelling, staphylococcal infection (What is staphylococcal infection?). Marcaine dosage: . Patient was hospitalized.

6369367-1 | Arthritis Infective
on Sep 08, 2009 Male patient from UNITED STATES , 50 years of age, was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: arthritis infective. Marcaine dosage: Not Reported. Patient was hospitalized.

6340880-6 | Gait Disturbance, Muscular Weakness, Sensory Disturbance
Patient was taking Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, muscular weakness, sensory disturbance on Aug 26, 2009 from JAPAN Additional patient health information: Female patient , 29 years of age, weighting 143.3 lb, was diagnosed with spinal anaesthesia, epidural anaesthesia and. Marcaine dosage: . During the same period patient was treated with ANAPEINE INJECTION (360 Mg/3 Days) (View Anapeine Injection Review and Anapeine Injection Label ), EPHEDRINE HYDROCHLORIDE (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ). Patient was hospitalized.

6308432-1 | Anaphylactic Shock
Adverse event was reported on Aug 06, 2009 by a Male patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia, nerve block, preoperative care, hypertension, constipation (What is constipation?) and. Location: JAPAN , 77 years of age, weighting 99.21 lb, Patient had the following side effects: anaphylactic shock. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), CEFAMEZIN (View Cefamezin Review and Cefamezin Label ), BLOPRESS (View Blopress Review and Blopress Label ), PURSENNID (View Pursennid Review and Pursennid Label ).

6278321-X | Dyspnoea, Rash
on Jul 14, 2009 Female patient from UNITED KINGDOM , 84 years of age, weighting 141.1 lb, was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: dyspnoea, rash (What is rash?). Marcaine dosage: . During the same period patient was treated with KENALOG (View Kenalog Review and Kenalog Label ), ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), NULYTELY (View Nulytely Review and Nulytely Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6271827-9 | Asthenia, Chondrolysis, Chondromalacia, Intracranial Venous Sinus Thrombosis, Joint Crepitation, Joint Range Of Motion Decreased, Musculoskeletal Pain, Neuromyopathy, Rotator Cuff Syndrome
on Jul 06, 2009 Female patient from UNITED STATES , 28 years of age, was diagnosed with musculoskeletal pain and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chondrolysis, chondromalacia, intracranial venous sinus thrombosis, joint crepitation, joint range of motion decreased, musculoskeletal pain, neuromyopathy, rotator cuff syndrome. Marcaine dosage: 100 Ml, 0.5%, 2 Ml/hr, Continuous Over 4-5 Days, Intra-articular. During the same period patient was treated with I FLOW ON Q PAINBUSTER PAIN PUMP (View I-flow On-q Painbuster Pain Pump Review and I-flow On-q Painbuster Pain Pump Label ).

6270699-6 | Extradural Haematoma
Patient was taking Marcaine (View Usage). Patient had the following side effects: extradural haematoma on Jul 07, 2009 from JAPAN Additional patient health information: Male patient , 76 years of age, weighting 114.6 lb, was diagnosed with spinal anaesthesia and. Marcaine dosage: .

6263963-8 | Meningitis
Adverse event was reported on May 29, 2008 by a Female patient taking Marcaine (View Usage) (Dosage: Epidural) was diagnosed with spinal anaesthesia and. Location: UNITED STATES , 23 years of age, After Marcaine was administered, patient had the following side effects: meningitis (What is meningitis?). Patient was hospitalized.

6254080-1 | Anaphylactic Shock
on Jun 24, 2009 Male patient from JAPAN , 77 years of age, was diagnosed with spinal anaesthesia, local anaesthesia and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Marcaine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), CEFAMEZIN (View Cefamezin Review and Cefamezin Label ).

6253729-7 | Cellulitis, Chondrolysis, Chondromalacia, Debridement, Discomfort, Graft Loss, Inflammatory Pain, Injection Site Discharge, Injection Site Erythema
on Jun 19, 2009 Female patient from UNITED STATES , 39 years of age, was diagnosed with musculoskeletal pain, nerve block, anaesthesia and was treated with Marcaine (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), chondrolysis, chondromalacia, debridement, discomfort, graft loss, inflammatory pain, injection site discharge, injection site erythema. Marcaine dosage: 120 Ml, 0.5% Continous Via Pain Pump; 120 Mg, 2.08 Mg/hr Continous Via Pain Pump; 3ml. During the same period patient was treated with SENSORCAINE (120 Mg, 0.5% Continuous Via Pain Pump) (View Sensorcaine Review and Sensorcaine Label ), ROPIVACAINE (ROPIVACAINE) (See Image) (View Ropivacaine (ropivacaine) Review and Ropivacaine (ropivacaine) Label ).

6248968-5 | Abscess, Chondrolysis, Movement Disorder, Musculoskeletal Pain
Patient was taking Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: abscess (What is abscess?), chondrolysis, movement disorder (What is movement disorder?), musculoskeletal pain on Jun 10, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 202.0 lb, was diagnosed with infiltration anaesthesia, musculoskeletal pain and. Marcaine dosage: 400 Ml, 0.5% Continuous Via Pain Pump, 0.5%. During the same period patient was treated with I FLOW ON Q PAINBUSTER PUMP (View I-flow On-q Painbuster Pump Review and I-flow On-q Painbuster Pump Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), IMODIUM (View Imodium Review and Imodium Label ), ANCEF (View Ancef Review and Ancef Label ).

6248798-4 | Anaphylactic Shock, Cardiac Arrest
Adverse event was reported on Jun 23, 2009 by a Male patient taking Marcaine (View Usage) (Dosage: ) was diagnosed with spinal anaesthesia, coronary artery disease (What is coronary artery disease?), myocardial fibrosis, angina pectoris and. Location: RUSSIAN FEDERATION , 67 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?). During the same period patient was treated with NOVOCAINE (View Novocaine Review and Novocaine Label ), POTASSIUM AND MAGNESIUM ASPARAGINATE (View Potassium And Magnesium Asparaginate Review and Potassium And Magnesium Asparaginate Label ), KETOROL (View Ketorol Review and Ketorol Label ).

6232973-9 | Muscular Weakness
on Jun 02, 2009 Male patient from SWEDEN , weighting 195.6 lb, was diagnosed with procedural pain and was treated with Marcaine (View Usage). Patient had the following side effects: muscular weakness. Marcaine dosage: . Patient was hospitalized.

6231555-2 | Extradural Haematoma
on Jun 08, 2009 Male patient from JAPAN , 76 years of age, weighting 114.6 lb, was diagnosed with spinal anaesthesia and was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: extradural haematoma. Marcaine dosage: .

6216976-6 | Arthralgia, Arthritis, Bursa Removal, Chondrolysis, Chondromalacia, Joint Range Of Motion Decreased, Musculoskeletal Pain, Periarthritis, Radiculopathy
Patient was taking Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, arthritis (What is arthritis?), bursa removal, chondrolysis, chondromalacia, joint range of motion decreased, musculoskeletal pain, periarthritis, radiculopathy on May 20, 2009 from UNITED STATES Additional patient health information: Female patient , 41 years of age, was diagnosed with local anaesthesia, musculoskeletal pain and. Marcaine dosage: 270 Ml, 0.25% Continous Via Pump, Intra-articular. During the same period patient was treated with MARCAINE HYDROCHLORIDE W/ EPINEPHRINE (20 Ml, 0.25% Right Shoulder Intra-articular) (View Marcaine Hydrochloride W/ Epinephrine Review and Marcaine Hydrochloride W/ Epinephrine Label ), PAIN PUMP (View Pain Pump Review and Pain Pump Label ), ANCEF (View Ancef Review and Ancef Label ), LACTATED RINGERS (FLEBOBAG RING LACT) (View Lactated Ringers (flebobag Ring Lact) Review and Lactated Ringers (flebobag Ring Lact) Label ).

6211055-6 | Chondrolysis, Haemorrhage, Hypersensitivity, Joint Abscess, Necrosis, Purulence, Repetitive Strain Injury, Suture Related Complication
Adverse event was reported on May 19, 2009 by a Male patient taking Marcaine (View Usage) (Dosage: 400 Ml, 0.5% Continuous Via Pain Pump; 0.5%) was diagnosed with extravasation, musculoskeletal pain and. Location: UNITED STATES , 61 years of age, weighting 202.0 lb, Patient had the following side effects: chondrolysis, haemorrhage, hypersensitivity, joint abscess, necrosis, purulence, repetitive strain injury, suture related complication. During the same period patient was treated with I FLOW ON Q PAINBUSTER PUMP (View I-flow On-q Painbuster Pump Review and I-flow On-q Painbuster Pump Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), IMODIUM (View Imodium Review and Imodium Label ), ANCEF (View Ancef Review and Ancef Label ).

6210900-8 | Chondrolysis, Chondromalacia, Musculoskeletal Pain
on May 20, 2009 Female patient from UNITED STATES , 41 years of age, was diagnosed with musculoskeletal pain, local anaesthesia and was treated with Marcaine (View Usage). After Marcaine was administered, patient had the following side effects: chondrolysis, chondromalacia, musculoskeletal pain. Marcaine dosage: 270 Ml, 0.25% Continuous Via Pain Pump, Intra-articular.

6198450-9 | Cold Sweat, Hypotension, Nausea, Nerve Injury, Tachycardia
on May 13, 2009 Male patient from TURKEY , 72 years of age, was diagnosed with spinal anaesthesia, postoperative analgesia and was treated with Marcaine (View Usage). Patient experienced the following unwanted or unexpected effects: cold sweat, hypotension, nausea (What is nausea?), nerve injury, tachycardia. Marcaine dosage: . During the same period patient was treated with GLUTARALDEHYDE SOLUTION (View Glutaraldehyde Solution Review and Glutaraldehyde Solution Label ), SERUM PHYSIOLOGIC (View Serum Physiologic Review and Serum Physiologic Label ).

6192926-6 | Cardiac Arrest
Patient was taking Marcaine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on May 13, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , 67 years of age, weighting 143.3 lb, was diagnosed with spinal anaesthesia, coronary artery disease (What is coronary artery disease?), myocardial fibrosis, angina pectoris and. Marcaine dosage: . During the same period patient was treated with NOVOCAINE (View Novocaine Review and Novocaine Label ), POTASSIUM AND MAGNESIUM ASPARAGINATE (View Potassium And Magnesium Asparaginate Review and Potassium And Magnesium Asparaginate Label ), ADRENALINE HYDROCHLORIDE (1 Drop With Marcaine Spinal) (View Adrenaline Hydrochloride Review and Adrenaline Hydrochloride Label ), KETOROL (View Ketorol Review and Ketorol Label ).